Aspira Pathlab Complete Financial Statements

ASPIRA • Review detailed financials to uncover trends, confirm thesis & journal trades
3 Years of Data
2025 - 2023

Complete Financial Data Export

Export complete financial statements for Aspira Pathlab (ASPIRA). Downloads include all available records across all periods. For market performance, see the ASPIRA stock price today .

Profitability Ratios

Net Profit Margin 16.67% 2025 data
EBITDA Margin 16.67% 2025 data
Operating Margin 16.00% 2025 data
Return on Assets 5.56% 2025 data
Return on Equity 8.33% 2025 data

Balance Sheet Ratios

Current Ratio 1.67 2025 data
Debt to Equity 1.50 2025 data
Equity Ratio 66.67% 2025 data
Asset Turnover 0.33 2025 data

Year-over-Year Growth Analysis

Comparing Mar 2024 vs Mar 2025
Revenue Growth
+50.0%
Year-over-Year
Net Profit Growth
+200.0%
Year-over-Year
Expense Growth
+25.0%
Year-over-Year
Assets Growth
+20.0%
Year-over-Year
Equity Growth
+20.0%
Year-over-Year
Liabilities Growth
+20.0%
Year-over-Year
Operating Cash Flow Growth
+100.0%
Year-over-Year

Income Statement

Periods ₹ Crores
Particulars Mar 2025 Jun 2025 Sept 2024 Mar 2024 Jun 2024 Dec 2024 Jun 2023
Revenue 6 5 6 4 5 6 3
Expenses 5 5 5 4 4 5 3
EBITDA 1 1 1 0 0 1 0
Operating Profit Margin % 16.00% 13.00% 21.00% -5.00% 6.00% 11.00% -17.00%
Depreciation 0 0 0 0 0 0 0
Interest 0 0 0 0 0 0 0
Profit Before Tax 1 0 1 -1 0 0 -1
Tax 0 0 0 0 0 0 0
Net Profit 1 0 1 -1 0 0 -1
Earnings Per Share (₹) 0.66 0.41 0.96 -0.49 0.05 0.30 -0.70

Balance Sheet

Years Annual Data ₹ Crores
Particulars 2025 2024
ASSETS
Total Assets 18 15
Current Assets 5 4
Fixed Assets 7 7
Capital Work in Progress 0 0
Investments 0 0
Other Assets 11 8
LIABILITIES
Total Liabilities 18 15
Current Liabilities 3 3
Non-Current Liabilities
SHAREHOLDERS' EQUITY
Total Equity 12 10
Share Capital 10 10
Reserves & Surplus -3 -5

Cash Flow Statement

Periods ₹ Crores
Particulars March 2025 March 2024
Operating Activities 2 1
Investing Activities 0 0
Financing Activities -1 -1
Net Cash Flow 1 0